HEPATITIS C VIRUS CHRONIC INFECTION
Clinical trials for HEPATITIS C VIRUS CHRONIC INFECTION explained in plain language.
Never miss a new study
Get alerted when new HEPATITIS C VIRUS CHRONIC INFECTION trials appear
Sign up with your email to follow new studies for HEPATITIS C VIRUS CHRONIC INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hep c pill combo takes on standard therapy in major trial
Disease control Recruiting nowThis study compares a new oral medication, Bemnifosbuvir-Ruzasvir, to the current standard treatment, Sofosbuvir-Velpatasvir, for adults with chronic hepatitis C. About 880 participants who have not taken similar drugs before will receive one of the two treatments. The main goal …
Matched conditions: HEPATITIS C VIRUS CHRONIC INFECTION
Phase: PHASE3 • Sponsor: Atea Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New supplement cocktail aims to ease hepatitis c liver damage
Disease control Recruiting nowThis study tests a nutritional supplement containing resveratrol, quercetin, taurine, inulin, and whey protein in 26 adults with liver disease from chronic hepatitis C. Participants take the supplement or whey protein alone daily for 12 weeks. Researchers will check liver functio…
Matched conditions: HEPATITIS C VIRUS CHRONIC INFECTION
Phase: NA • Sponsor: University of Guadalajara • Aim: Disease control
Last updated May 04, 2026 16:23 UTC